15813090

Source:http://linkedlifedata.com/resource/pubmed/id/15813090

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0015196, umls-concept:C0034642, umls-concept:C0034656, umls-concept:C0591054
pubmed:dateCreated	2005-4-7
pubmed:language	jpn
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0420546
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Aldosterone Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Spironolactone
pubmed:status	MEDLINE
pubmed:month	Mar
pubmed:issn	0047-1852
pubmed:author	pubmed-author:KigoshiToshikazuT, pubmed-author:NakanoShigeruS, pubmed-author:UchidaKenzoK
pubmed:issnType	Print
pubmed:volume	63 Suppl 3
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	330-5
pubmed:dateRevised	2011-7-27
pubmed:meshHeading	pubmed-meshheading:15813090-Aldosterone Antagonists, pubmed-meshheading:15813090-Double-Blind Method, pubmed-meshheading:15813090-Heart Failure, pubmed-meshheading:15813090-Humans, pubmed-meshheading:15813090-Spironolactone
pubmed:year	2005
pubmed:articleTitle	[Randomized Aldactone Evaluation Study (RALES)].
pubmed:affiliation	Division of Endocrinology and Metabolism, Department of Internal Medicine, Kanazawa Medical University.
pubmed:publicationType	Journal Article, Clinical Trial, Randomized Controlled Trial